Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012

Authors

  • Maryam Mohammadian
  • Reza Pakzad
  • Farhad Towhidi
  • Behnam Reza Makhsosi
  • Abbas Ahmadi
  • Hamid Salehiniya

DOI:

https://doi.org/10.15386/cjmed-691

Keywords:

incidence, mortality, kidney cancer, Human Development Index

Abstract

Background and aims. Kidney cancer is among the cancers that have the highest growth rate in all age and racial groups in the world and is as the most deadly type of urinary tract cancer. Since awareness about this cancer incidence status and mortality is essential for better planning, this study aimed to investigate the incidence and mortality rate of kidney cancer and its relationship with the development index in the world in 2012.

Method. This study was an ecological study conducted based on GLOBOCAN project of the World Health Organization (WHO) for the countries in the world. The correlation between Standardized Incidence Rates (SIRs) and Standardized Mortality Rates (SMRs) of kidney cancer with HDI and its components was assessed using SPSS18.

Results. In total, 337,860 incidence cases (213,924 were men and 123,936 women) and 143,406 deaths (90,802 cases in men and 52,604 in women) of kidney cancer were recorded in 2012. A positive correlation of 0.731 was seen between SIR of kidney cancer and HDI (p≤0.001). Also, a negative correlation of 0.627was seen between SMR of kidney cancer and HDI (p≤0.001).

 Conclusion. The incidence and mortality rate of kidney cancer is higher in developed countries. A significant positive correlation has been seen between the standardized incidence and mortality rate of kidney cancer with the Human Development Index and its components. We need more studies to examine variation in incidence and mortality of kidney cancer and its related factors in the world.

Author Biographies

Maryam Mohammadian, Health Promotion Research Center, Department of Epidemiology and Biostatistics, School of Public Health , Zahedan University of Medical Sciences, Zahedan, Iran

Health Promotion Research Center, Department of Epidemiology and Biostatistics, School of Public Health , Zahedan University of Medical Sciences, Zahedan, Iran

Reza Pakzad, Student Research committee, Ilam University of Medical Sciences, Ilam, Iran

Student Research committee, Ilam University of Medical Sciences, Ilam, Iran

Farhad Towhidi, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Behnam Reza Makhsosi, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran;

  Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran;

Abbas Ahmadi, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran;

Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran;

Hamid Salehiniya, Zabol university of Medical Sciences, Zabol, Iran Department of Epidemiology and Biostatistics, school of public health, Tehran University of medical sciences, Tehran, Iran

TUMS

Downloads

Additional Files

Published

2017-07-25

How to Cite

1.
Mohammadian M, Pakzad R, Towhidi F, Makhsosi BR, Ahmadi A, Salehiniya H. Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012. Med Pharm Rep [Internet]. 2017 Jul. 25 [cited 2025 Oct. 5];90(3):286-93. Available from: https://medpharmareports.com/index.php/mpr/article/view/691

Issue

Vol. 90 No. 3 (2017)

Section

Original Research

License

The authors are required to transfer the copyright of the published paper to the journal. This is done by agreeing to sign the Copyright Assignment Form. Whenever the case, authors are also required to send permissions to reproduce material (such as illustrations) from the copyright holder.

 Creative Commons License
The papers published in the journal are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.